Post by BeOne Medicines
253,646 followers
At #EHA2026, we’re highlighting new long-term data in a CLL population that has often been underrepresented in clinical trials: patients aged 80 and older. Hear from Dany Habr, M.D., our Head of Medical Affairs, North America & International Markets, on why this data helps address an important evidence gap for the patients clinicians treat every day. Learn more about BeOne at EHA: https://lnkd.in/gqumyPDr #FromFloorToFeed #TeamBeOne
Video Content